The Minority Graduate Student Abstract Achievement Award is part of the ASH Abstract Achievement Award program. This award program is meant to encourage minority graduate students in the field of hematology and is part of the broader minority recruitment initiative at ASH, which also includes the Minority Medical Student Award Program (MMSAP), the Minority Resident Hematology Award Program (MRHAP), and the ASH-Harold Amos Medical Faculty Development Program (ASH-AMFDP) in partnership with the Robert Wood Johnson Foundation. The goal of the Minority Graduate Student Abstract Achievement Award is to attract and retain minority PhD students to the field of hematology through the ASH annual meeting. At this meeting, students will have the opportunity to hear the latest advances in hematology-related research and interact with ASH leadership, senior researchers, and minority physicians, scientists, and students. These awards go to select graduate students to acknowledge their accomplishments in the field of hematology.
Daisy Diaz Rohena, BS
MD Anderson Cancer Center
Abstract 2252
Title: Targeting Venetoclax-Resistant CLL By Bcl-XL Degradation
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II
Sunday, December 12, 2021, 6:00 a.m. - 8:00 p.m. Eastern time
Mary Figueroa, BS
MD Anderson Cancer Center
Abstract 3331
Title: Cigarette Smoke or Cigarette Condensate Exposure Accelerates Growth of FLT3-ITD AML Models, Induces Oxidative Stress, and Alters DNA Methylation
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III
Monday, December 13, 2021, 6:00 a.m. - 8:00 p.m. Eastern time
Marcus Florez, BS
Baylor College of Medicine
Abstract 1098
Title: Bone Marrow Stromal Antigen 2 Facilitates Activation of Hematopoietic Stem Cell through the Induction of ERK Signaling
506. Hematopoiesis and Stem Cells: Microenvironment: Poster I
Saturday, December 11, 2021, 5:30 a.m. - 7:30 p.m. Eastern time
Juan Ibarra, MSc
University of Chicago Abstract 628
Title: Type 1 Calreticulin Mutations Differentially Activate the IRE1α-XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational II
Monday, December 13, 2021, 11:15 a.m. Eastern time
Taylor Mills, BA
University of Colorado
Abstract 2165
Title: Hematopoietic Stem Cells Undergo Immune Training and Constitute a Long-Term Reservoir for Hyper-Inflammatory Macrophages in a Mouse Model of Chronic Autoimmunity
503. Clonal Hematopoiesis, Aging and Inflammation: Poster II
Sunday, December 12, 2021, 6:00 a.m. - 8:00 p.m. Eastern time
Bianca Ulloa, MS
Williams College
Abstract 3268
Title: Definitive Hematopoietic Stem Cells Minimally Contribute to Embryonic Hematopoiesis
501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster III
Monday, December 13, 2021, 6:00 a.m. - 8:00 p.m. Eastern time
Zollie White III, BS
University of Virginia
Abstract 936
Title: The Loss of Liver Kinase B1 Accelerates Maturation Time in the Developing Erythrocyte
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I
Saturday, December 11, 2021, 5:30 a.m. - 7:30 p.m. Eastern time